Page last updated: 2024-10-16

carbon monoxide and Pulmonary Sarcoidosis

carbon monoxide has been researched along with Pulmonary Sarcoidosis in 18 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Research Excerpts

ExcerptRelevanceReference
"67Ga lung uptake, obtained by a standardized computer-assisted quantitative method of 67Ga scintigraphy, was compared to carbon monoxide diffusion capacity (DLCO) in 45 patients with biopsy proven pulmonary sarcoidosis."7.68Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis. ( Alberts, C; Jansen, HM; Kuipers, AF; Roos, CM; van der Schoot, JB, 1993)
"In 149 patients with proven pulmonary sarcoidosis the alveolar-arterial oxygen pressure gradient (P(A-a)O(2)) during exercise was assessed and compared with chest X-ray typing, pulmonary function, single breath-diffusing capacity for carbon monoxide (DL(CO)), serological markers, cell composition of bronchoalveolar lavage fluid (BALF) and clinical course."3.77The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. ( Arzt, M; Budweiser, S; Geck, B; Hamer, OW; Heidinger, D; Jörres, RA; Kollert, F; Müller-Quernheim, J; Pfeifer, M; Prasse, A; Suchy, R, 2011)
"67Ga lung uptake, obtained by a standardized computer-assisted quantitative method of 67Ga scintigraphy, was compared to carbon monoxide diffusion capacity (DLCO) in 45 patients with biopsy proven pulmonary sarcoidosis."3.68Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis. ( Alberts, C; Jansen, HM; Kuipers, AF; Roos, CM; van der Schoot, JB, 1993)
"Sarcoidosis is a systemic inflammatory disease characterized by non-necrotizing granulomas in involved organs, most commonly the lung."1.46Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort. ( Arger, NK; Benn, BS; Gelfand, JM; Gomez, A; Ho, M; Kidd, SA; Koth, LL; Lehman, Z; Nguyen, CP; Ramstein, J; Su, R; Sun, S, 2017)
"Different interstitial lung diseases may show distinct lymphocyte activation profiles."1.36T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? ( Claessen, AM; Grutters, JC; Heron, M; van den Bosch, JM, 2010)
"Pulmonary fibrosis is defined by an overgrowth of fibroblasts and extracellular matrix deposition, and results in respiratory dysfunction that is often fatal."1.36MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. ( Grutters, JC; Kazemier, KM; Korthagen, NM; Nagtegaal, MM; van den Bosch, JM; van Moorsel, CH, 2010)
"Pulmonary hypertension was found in 34."1.36[Sarcoidosis. Clinical presentation and prognosis]. ( Cáneva, J; González, EL; Vigliano, C, 2010)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's5 (27.78)29.6817
2010's11 (61.11)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Shlobin, OA1
Kouranos, V2
Barnett, SD1
Alhamad, EH1
Culver, DA1
Barney, J1
Cordova, FC1
Carmona, EM1
Scholand, MB1
Wijsenbeek, M1
Ganesh, S1
Lower, EE1
Engel, PJ1
Wort, J1
Price, L1
Wells, AU3
Nathan, SD1
Baughman, RP2
Benn, BS1
Lehman, Z1
Kidd, SA1
Ho, M1
Sun, S1
Ramstein, J1
Arger, NK1
Nguyen, CP1
Su, R1
Gomez, A1
Gelfand, JM1
Koth, LL1
Kaminsky, DA1
Jarzembowski, SC1
Zappala, CJ1
Desai, SR1
Copley, SJ1
Spagnolo, P1
Sen, D1
Alam, SM1
du Bois, RM1
Hansell, DM1
Lill, H1
Kliiman, K1
Altraja, A1
Ciarleglio, G1
Refini, RM1
Pieroni, MG1
Martino, VA1
Bargagli, E1
Rottoli, P1
Sestini, P1
Heron, M1
Claessen, AM1
Grutters, JC2
van den Bosch, JM2
Korthagen, NM1
Nagtegaal, MM1
van Moorsel, CH1
Kazemier, KM1
Kollert, F1
Geck, B1
Suchy, R1
Jörres, RA1
Arzt, M1
Heidinger, D1
Hamer, OW1
Prasse, A1
Müller-Quernheim, J1
Pfeifer, M1
Budweiser, S1
González, EL1
Vigliano, C1
Cáneva, J1
Erdal, BS1
Crouser, ED1
Yildiz, V1
King, MA1
Patterson, AT1
Knopp, MV1
Clymer, BD1
Marcellis, RG1
Lenssen, AF1
de Vries, GJ1
van der Grinten, CP1
Verschakelen, JA1
De Vries, J1
Drent, M1
Rapti, A1
Gialafos, E1
Aggeli, K1
Moyssakis, J1
Kallianos, A1
Kostopoulos, C1
Anagnostopoulou, O1
Sfikakis, PP1
Tzelepis, GE1
Mihailovic-Vucinic, V1
Zugic, V1
Videnovic-Ivanov, J1
Phansalkar, AR1
Hanson, CM1
Shakir, AR1
Johnson, RL1
Hsia, CC1
Lamberto, C1
Nunes, H1
Le Toumelin, P1
Duperron, F1
Valeyre, D1
Clerici, C1
Kadota, J1
Mizunoe, S1
Mito, K1
Mukae, H1
Yoshioka, S1
Kawakami, K1
Koguchi, Y1
Fukushima, K1
Kon, S1
Kohno, S1
Saito, A1
Uede, T1
Nasu, M1
Kuipers, AF1
Alberts, C1
Roos, CM1
van der Schoot, JB1
Jansen, HM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Physical Training in Sarcoidosis Patients With Fatigue Complaints[NCT02243995]40 participants (Actual)Interventional2013-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for carbon monoxide and Pulmonary Sarcoidosis

ArticleYear
New observations on pulmonary function changes in sarcoidosis.
    Current opinion in pulmonary medicine, 2003, Volume: 9, Issue:5

    Topics: Bronchial Provocation Tests; Carbon Monoxide; Humans; Respiratory Function Tests; Sarcoidosis, Pulmo

2003

Other Studies

17 other studies available for carbon monoxide and Pulmonary Sarcoidosis

ArticleYear
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
    The European respiratory journal, 2020, Volume: 55, Issue:5

    Topics: Aged; Carbon Monoxide; Cardiac Catheterization; Female; Forced Expiratory Volume; Hemodynamics; Huma

2020
Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adult; Age Factors; Aged; Black or African American; Carbon Monoxide; Case-Control Studies; Cohort S

2017
Influence of Mouth Pressure on Measurement of Diffusing Capacity in the Clinical Pulmonary Function Laboratory.
    Respiratory care, 2019, Volume: 64, Issue:5

    Topics: Adult; Aged; Asthma; Breath Holding; Carbon Monoxide; Dyspnea; Female; Forced Expiratory Volume; Hum

2019
Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data.
    Chest, 2014, Volume: 145, Issue:1

    Topics: Adult; Breath Tests; Carbon Monoxide; Disease Progression; Female; Forced Expiratory Volume; Humans;

2014
Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population.
    The clinical respiratory journal, 2016, Volume: 10, Issue:3

    Topics: Adult; Carbon Monoxide; Estonia; Female; Humans; Lung; Male; Middle Aged; Regression Analysis; Sarco

2016
Exhaled carbon monoxide in sarcoidosis.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2008, Volume: 25, Issue:1

    Topics: Adult; Biomarkers; Breath Tests; Carbon Monoxide; Carboxyhemoglobin; Diagnosis, Differential; Exhala

2008
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?
    Clinical and experimental immunology, 2010, Volume: 160, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Aged; Alveolitis, Extrinsic Allergic; Antigens, CD; Bronchoalveolar

2010
MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Clinical and experimental immunology, 2010, Volume: 161, Issue:2

    Topics: Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; Calgranulin B; Carbon Monoxide; Cell Count; F

2010
The impact of gas exchange measurement during exercise in pulmonary sarcoidosis.
    Respiratory medicine, 2011, Volume: 105, Issue:1

    Topics: Adult; Bronchoalveolar Lavage Fluid; Carbon Monoxide; Exercise Test; Exercise Tolerance; Female; Hum

2011
[Sarcoidosis. Clinical presentation and prognosis].
    Medicina, 2010, Volume: 70, Issue:6

    Topics: Adult; Aged; Argentina; Carbon Monoxide; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary;

2010
Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis.
    Chest, 2012, Volume: 142, Issue:6

    Topics: Carbon Monoxide; Humans; Image Processing, Computer-Assisted; Lung; Respiratory Function Tests; Sarc

2012
Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?
    Lung, 2013, Volume: 191, Issue:1

    Topics: Adult; Biomarkers; Breath Tests; Carbon Monoxide; Exercise Test; Exercise Tolerance; Female; Humans;

2013
Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.
    Lung, 2013, Volume: 191, Issue:1

    Topics: Adult; Aged; Arterial Pressure; Biomarkers; Carbon Monoxide; Comorbidity; Cross-Sectional Studies; F

2013
Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis.
    American journal of respiratory and critical care medicine, 2004, May-01, Volume: 169, Issue:9

    Topics: Adult; Analysis of Variance; Bias; Blood Volume; Breath Tests; Carbon Monoxide; Cardiac Output; Case

2004
Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
    Chest, 2004, Volume: 125, Issue:6

    Topics: Adult; Capillaries; Carbon Monoxide; Exercise Test; Female; Humans; Male; Membranes; Middle Aged; Mu

2004
High plasma concentrations of osteopontin in patients with interstitial pneumonia.
    Respiratory medicine, 2005, Volume: 99, Issue:1

    Topics: Adult; Aged; Biomarkers; Carbon Monoxide; Female; Humans; Immunoenzyme Techniques; Lung Diseases, In

2005
Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis.
    Sarcoidosis, 1993, Volume: 10, Issue:1

    Topics: Adult; Carbon Monoxide; Female; Gallium Radioisotopes; Humans; Lung; Male; Pulmonary Diffusing Capac

1993